BRIEF-Deutsche Bank said to face possible $60 mln derivative loss-Bloomberg,citing sources
* Deutsche Bank said to face possible $60 million derivative loss- Bloomberg,citing sources Source https://bloom.bg/2se2XDX
March 28 U.S. FDA:
* FDA approves new eczema drug Dupixent
* FDA granted the application for Dupixent priority review and breakthrough therapy designation
* FDA granted the approval of Dupixent to Regeneron Pharmaceuticals Inc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)
TORONTO, June 27 Royal Bank of Canada on Tuesday agreed to pay C$21.8 million ($16.5 million) in compensation to clients who were charged excess fees for mutual fund products and fee-based accounts.